文献速递泌尿系结石

复发肾结石患者经验性与选择性预防治疗的尿液过饱和度随机试验:URINE试验

Urinary Supersaturation in a Randomized Trial Among Individuals With Recurrent Nephrolithiasis Comparing Empiric vs Selective Preventive Therapy: The URINE Trial.
PubMed 文献 · J Urol · 2026-06-30

本研究为单中心随机试验,纳入56例成人特发性复发性钙结石患者,比较经验性治疗(不依据尿液检测直接给予饮食液体咨询及吲达帕胺、枸橼酸钾)与选择性治疗(依据24小时尿液检测调整饮食及药物,包括吲达帕胺、枸橼酸钾和/或别嘌醇)对8周时尿草酸钙和磷酸钙过饱和度的影响。

要点

  • 经验性与选择性预防策略在8周时尿草酸钙和磷酸钙过饱和度无显著差异。
  • 两组在尿量、pH及钙、草酸、枸橼酸、尿酸、钠排泄上亦无显著差异。
  • 在高复发风险结石患者中,短期选择性检测指导治疗未显示优于经验性治疗。

核心结论

  • 在复发肾结石高危个体中,经验性与选择性预防策略对尿液结石风险的影响无统计学显著差异。

研究设计与样本

  • 单中心随机试验,纳入56例成人特发性复发性钙结石患者,经验性组29例,选择性组27例。
  • 参与者在基线、4周和8周接受24小时尿液检测,主要结局为8周时尿草酸钙和磷酸钙过饱和度。

主要发现

  • 8周时两组尿量、pH及钙、草酸、枸橼酸、尿酸、钠排泄均无显著差异。

关键数值与推荐

  • 经验性组:饮食和液体咨询及吲达帕胺和枸橼酸钾药物治疗,不考虑24小时尿液结果。
  • 选择性组:根据基线和4周尿液检测调整饮食及药物(吲达帕胺、枸橼酸钾和/或别嘌醇)。

临床怎么用

  • 对于复发钙结石患者,短期经验性预防治疗与选择性检测指导治疗在降低尿液过饱和度方面效果相当。

局限性

  • 单中心短程试验,样本量较小(56例),随访仅8周。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We compare a strategy using testing to guide treatment, also known as selective therapy, with a strategy of initiating interventions without testing, termed empiric therapy, on urinary supersaturation of calcium oxalate and calcium phosphate. MATERIALS AND METHODS: In this single-center trial, adult individuals with recurrent idiopathic calcium stone disease were randomized to either an empiric or selective strategy. Participants received 24-hour urine testing at baseline, 4 weeks, and 8 weeks. Treatment in the empiric arm comprised dietary and fluid counseling and pharmacologic treatment with indapamide and potassium citrate irrespective of 24-hour urine results. For the selective arm, diet, and pharmacologic treatments, which included indapamide, potassium citrate, and/or allopurinol, were tailored based on urine testing at baseline and 4 weeks. The primary outcome was urinary supersaturation of calcium oxalate and calcium phosphate at 8 weeks. RESULTS: The analytic sample included 56 participants (mean [SD] age, 44.5 [13.2] years; 30 women [54%]), with 29 randomized to the empiric and 27 to the selective groups. At week 8, there were no significant differences comparing the empiric and selective arms with respect to mean [SD] urinary supersaturation of calcium oxalate (4.7 [2.9] vs 5.0 [2.9], P = .81) or calcium phosphate (1.3 [0.9] vs 1.4 [1.1], P = .58). Similarly, there were no significant differences at 8 weeks in urine volume and pH or in excretion of calcium, oxalate, citrate, uric acid, and sodium. CONCLUSIONS: In this short-term trial among individuals at high risk for stone recurrence, there was no statistically significant difference in the urinary stone risk comparing an empiric vs selective strategy for kidney stone prevention.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Hsi RS, Lee AX, Koyama T, et al. Urinary Supersaturation in a Randomized Trial Among Individuals With Recurrent Nephrolithiasis Comparing Empiric vs Selective Preventive Therapy: The URINE Trial. J Urol. 2026. PMID: 42378339. doi:10.1097/JU.0000000000005194

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。